GB2159173A - Transformation of hereditary material of plants - Google Patents
Transformation of hereditary material of plants Download PDFInfo
- Publication number
- GB2159173A GB2159173A GB08511630A GB8511630A GB2159173A GB 2159173 A GB2159173 A GB 2159173A GB 08511630 A GB08511630 A GB 08511630A GB 8511630 A GB8511630 A GB 8511630A GB 2159173 A GB2159173 A GB 2159173A
- Authority
- GB
- United Kingdom
- Prior art keywords
- gene
- process according
- protoplasts
- plant
- plants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000009466 transformation Effects 0.000 title claims description 72
- 239000000463 material Substances 0.000 title claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 146
- 210000001938 protoplast Anatomy 0.000 claims abstract description 104
- 238000000034 method Methods 0.000 claims abstract description 101
- 230000008569 process Effects 0.000 claims abstract description 61
- 210000004027 cell Anatomy 0.000 claims abstract description 58
- 238000012546 transfer Methods 0.000 claims abstract description 35
- 241000196324 Embryophyta Species 0.000 claims description 133
- 239000013612 plasmid Substances 0.000 claims description 59
- 108020004414 DNA Proteins 0.000 claims description 42
- 239000002202 Polyethylene glycol Substances 0.000 claims description 38
- 229920001223 polyethylene glycol Polymers 0.000 claims description 38
- 238000004520 electroporation Methods 0.000 claims description 26
- 101150062179 II gene Proteins 0.000 claims description 24
- 239000000725 suspension Substances 0.000 claims description 22
- 239000001963 growth medium Substances 0.000 claims description 21
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 19
- 244000061176 Nicotiana tabacum Species 0.000 claims description 18
- 238000002635 electroconvulsive therapy Methods 0.000 claims description 17
- 230000010354 integration Effects 0.000 claims description 9
- 238000005304 joining Methods 0.000 claims description 9
- 241000209504 Poaceae Species 0.000 claims description 8
- 230000000813 microbial effect Effects 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 230000010076 replication Effects 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 7
- 238000010276 construction Methods 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 235000011331 Brassica Nutrition 0.000 claims description 6
- 241000219198 Brassica Species 0.000 claims description 6
- 241000209082 Lolium Species 0.000 claims description 6
- 241000208125 Nicotiana Species 0.000 claims description 6
- 230000004927 fusion Effects 0.000 claims description 6
- 238000011534 incubation Methods 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 5
- 230000037431 insertion Effects 0.000 claims description 5
- 241000219193 Brassicaceae Species 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- 240000007377 Petunia x hybrida Species 0.000 claims description 4
- 108700001094 Plant Genes Proteins 0.000 claims description 4
- 241000208292 Solanaceae Species 0.000 claims description 4
- 150000001768 cations Chemical class 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 240000002791 Brassica napus Species 0.000 claims description 3
- 235000011293 Brassica napus Nutrition 0.000 claims description 3
- 241001495123 Hyoscyamus muticus Species 0.000 claims description 3
- 239000001506 calcium phosphate Substances 0.000 claims description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 3
- 235000011010 calcium phosphates Nutrition 0.000 claims description 3
- 238000000975 co-precipitation Methods 0.000 claims description 3
- 230000000536 complexating effect Effects 0.000 claims description 3
- 239000002502 liposome Substances 0.000 claims description 3
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims description 3
- 108010055896 polyornithine Proteins 0.000 claims description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 3
- 241000219317 Amaranthaceae Species 0.000 claims description 2
- 241000208838 Asteraceae Species 0.000 claims description 2
- 241000220485 Fabaceae Species 0.000 claims description 2
- 241000234280 Liliaceae Species 0.000 claims description 2
- 241000234615 Musaceae Species 0.000 claims description 2
- 241001107098 Rubiaceae Species 0.000 claims description 2
- 241001093501 Rutaceae Species 0.000 claims description 2
- 241001122767 Theaceae Species 0.000 claims description 2
- 241000219094 Vitaceae Species 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- -1 calcium cations Chemical class 0.000 claims description 2
- 230000001568 sexual effect Effects 0.000 claims description 2
- 108700028146 Genetic Enhancer Elements Proteins 0.000 claims 3
- 241000234670 Bromeliaceae Species 0.000 claims 1
- 230000000392 somatic effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 24
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 20
- 229930027917 kanamycin Natural products 0.000 description 19
- 229960000318 kanamycin Drugs 0.000 description 19
- 229930182823 kanamycin A Natural products 0.000 description 19
- 239000002609 medium Substances 0.000 description 16
- 239000012634 fragment Substances 0.000 description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 240000008100 Brassica rapa Species 0.000 description 8
- 235000011292 Brassica rapa Nutrition 0.000 description 8
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 8
- 229930195725 Mannitol Natural products 0.000 description 8
- 238000004113 cell culture Methods 0.000 description 8
- 230000002068 genetic effect Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 239000000594 mannitol Substances 0.000 description 8
- 235000010355 mannitol Nutrition 0.000 description 8
- 244000100545 Lolium multiflorum Species 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 229960004793 sucrose Drugs 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 6
- 241000701489 Cauliflower mosaic virus Species 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000012526 feed medium Substances 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- 108010025815 Kanamycin Kinase Proteins 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002105 Southern blotting Methods 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 102000006646 aminoglycoside phosphotransferase Human genes 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 244000309466 calf Species 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 235000013681 dietary sucrose Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 210000003855 cell nucleus Anatomy 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 235000021186 dishes Nutrition 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 101150111412 npt gene Proteins 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 2
- 239000005971 1-naphthylacetic acid Substances 0.000 description 2
- OVSKIKFHRZPJSS-DOMIDYPGSA-N 2-(2,4-dichlorophenoxy)acetic acid Chemical compound OC(=O)[14CH2]OC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-DOMIDYPGSA-N 0.000 description 2
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 108010077805 Bacterial Proteins Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000218922 Magnoliophyta Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000209056 Secale Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 244000045561 useful plants Species 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- LGGQQYXFFSOIJY-UHFFFAOYSA-N 2-(3-methylbut-2-enyl)-7h-purin-6-amine Chemical compound CC(C)=CCC1=NC(N)=C2NC=NC2=N1 LGGQQYXFFSOIJY-UHFFFAOYSA-N 0.000 description 1
- ZVNPWFOVUDMGRP-UHFFFAOYSA-N 4-methylaminophenol sulfate Chemical compound OS(O)(=O)=O.CNC1=CC=C(O)C=C1.CNC1=CC=C(O)C=C1 ZVNPWFOVUDMGRP-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 244000296825 Amygdalus nana Species 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000723377 Coffea Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000009807 Cydonia Nutrition 0.000 description 1
- 241001507921 Cydonia Species 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000220223 Fragaria Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010013216 GATATC-specific type II deoxyribonucleases Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000208278 Hyoscyamus Species 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 108090000913 Nitrate Reductases Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 241000209117 Panicum Species 0.000 description 1
- 235000006443 Panicum miliaceum subsp. miliaceum Nutrition 0.000 description 1
- 235000009037 Panicum miliaceum subsp. ruderale Nutrition 0.000 description 1
- 241000219833 Phaseolus Species 0.000 description 1
- 241000219843 Pisum Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 235000005775 Setaria Nutrition 0.000 description 1
- 241000232088 Setaria <nematode> Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- 101150100931 VI gene Proteins 0.000 description 1
- 241001672648 Vieira Species 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 108010081495 driselase Proteins 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 230000003032 phytopathogenic effect Effects 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 101150010939 tpa gene Proteins 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8206—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/14—Plant cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Botany (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A novel process for the direct transfer of foreign genes to plant genomes comprises placing a gene under the control of plant expression signals and transferring it, by contact with protoplasts without the aid of natural systems for infecting plants, direct to plant cells from which genetically transformed plants can subsequently be derived.
Description
SPECIFICATION
Transformation of hereditary material of plants
The present invention relates to a novel process for transforming hereditary material of plants and to the plant products obtained by said process.
Plants having novel and/or improved properties can be produced by introducing new genetic information into plant material.
In view of the rapid rise in world population and the concomitant increase in the need for food and raw materials, increasing the yield of useful plants as well as the increased extraction of plant storage substances, and in particular advances in the field of nutrition and medicine, are among the most urgent tasks of biological research. In this connection, the following essential aspects may be mentioned by way of example: strengthening the resistance of useful plants to unfavourable soil or climatic conditions as well as to disease and pests; increasing resistance to plant protective agents such as insecticides, herbicides, fungicides and bactericides; and a useful change in the nutrient content or of the harvest yield of plants.
Such desirable effects could be produced generally by induction or increased formation of protective substances, valuable proteins or toxins. A corresponding influence on the hereditary material of plants can be brought about, for example, by inserting a specific foreign gene into plant cells without utilising conventional breeding methods.
The transfer of novel DNA sequences into plant cells using genetically manipulated plant infecting bacteria has been described in the literature in a number of publications, for example Nature, Vol.303,209-213 (1983); Nature, Vol. 304, 184-187 (1983); Scientific American 248(6), 50-59 (1983); EMBO-Journal 2(6), 987-995 (1983); Science 222, 476-482 (1983); Science 223, 247-248 (1984); or Proc. Natl. Acad. Sci. USA 80, 4803-4807 (1983). In these publications, the natural properties of these bacteria for infecting plants were utilised to insert new genetic material into plant cells. So far such insertion has been made using preferably
Agrobacterium tumefaciens itself or the Ti plasmid thereof, and also cauliflower mosaic virus.
In contradistinction thereto, the novel process of this invention makes possible the direct transfer of a gene without the use of biological vectors. Pathogens have been used as vectors in the known processes. As the process of this invention is performed without pathogens, the limitations imposed by the host specificity of pathogens also do not apply. The development of the plants on which the novel process of transformation is carried out is not impaired by said process.
In addition to the process for transforming hereditary material of plants, the present invention also relates to the products obtainable by said process, in particular protoplasts and plant material derived therefrom, for example cells and tissues, in particular complete plants that have been regenerated from said protoplasts and the genetically identical progeny thereof.
Within the scope of the present invention, the following definitions apply:
gene: structural gene with flanking expression signals
structural gene: protein-coding DNA sequence
expression signals: promoter signal and termination signal
plant expression
signal: expression signal that functions in plants
promoter signal: signal that initiates transcription
termination signal: signal that terminates transcription
enhancer signal: signal that promotes transcription
replication signal: signal that makes possible DNA replication
integration signal: DNA sequence that promotes the integration of the gene
into genomic DNA
hybrid gene: gene constructed from heterologous DNA sequences, i.e.
DNA sequences of different origin that may be natural as
well as synthetic DNA sequences
carrier DNA: a neutral (i.e. not participating in the function of the
gene) DNA sequence flanking the gene
isolated gene: DNA sequence coding for a single protein and separated
from the original DNA
NPT II gene: neomycin 3'-phosphotransferase gene, type II, of trans
poson Tn 5 [Rothstein, S.J. and W.S. Retznikoff, Cell 23, 191-199(1981)] genomic DNA: DNA of the plant genome (total or part thereof).
The present invention is concerned with a novel process forthe transformation of hereditary material of plants, which process comprises transferring a gene direct into plant cells without the aid of natural systems for infecting plants. Such transformation is accordingly a vector-free transformation. In this vector-free transformation, the foreign gene for insertion is under the control of plant expression signals. The vector-free transformation of plant genes is preferably carried out by introducing a foreign gene for insertion into plant cells togetherwith plant protoplasts acting as recipients (receptor protoplasts) into a suitable solution and leaving them until the gene has been taken up by the protoplasts.
As protoplasts it is preferred to use those of a single plant species or of a systematic unit which is a suborder of a species.
The foreign gene and the protoplasts are conveniently left in the solution for a period of time ranging from several seconds to several hours, preferably from 10 to 60 minutes, most preferably for 30 minutes.
The process of this invention is susceptible of broad application. Thus it is possible to transfer any structural genes of plant origin, for example the zein gene [Weinand, U., et al., Mol. Gen. Genet. 182, 440-444 (1981)], of animal origin, for example the TPA gene [tissue -type plasminogen activator gene; Pennica, D., et al., Nature 301, 214-221(1983)], of microbial origin, for example the NPT II gene, or also of synthetic origin, for example the insulin gene [Stepien, P., et al., Gene 24, 289-297 (1983)], into hereditary' material of plants, provided that the structural genes are flanked by expression signals which are expressed in plants and which expression signals may be of plant, animal, microbial or synthetic origin.
The transferred genes, consisting of structural gene and flanking expression signals, may be naturally occurring genes as well as hybrid genes. In the process of this invention, it is preferred to use those genes whose expression signals are of animal or, in particular, of plant or synthetic origin.Exemplary of such genes are:
a) complete genes of plants consisting of the structural gene with its natural expression signals;
b) completely synthetic genes consisting of a structural gene of synthetic origin, flanked by expression signals of synthetic origin;
c) structural genes of plant origin, flanked by plant expression signals, with the structures and expression signals originating from various plant species;
d) structural genes of plant origin, flanked by expression signals of synthetic origin;
e) structural genes of animal, microbial or synthetic origin, flanked by expression signals of plant origin; or
f) structural genes of animal or microbial origin, flanked by expression signals of synthetic origin.
Most preferred are structural genes of bacterial origin, flanked by expression signals of plant origin, in particular those originating from plant viruses. Particularly suitable expression signals for use in the process of this invention are the expression signals of gene VI of cauliflower mosaic virus.
The hybrid genes are prepared by microbiological techniques which are known per se, retaining the reading frame of the coding for the proteins to be produced by the plant cell. Such techniques are known and are described e.g. in the following publications: "Molecular Cloning", Maniatis, T., Fritsch, E.F. and J.
Sambrook, Cold Spring Harbor Laboratory, 1982, and "recombinant DNA Techniques", Rodriguez, R.L. and
R.C. Tait, Addison-Wesley Publishing Comp., London, Amsterdam, Don Mills. Ontario, Sydney, Tokyo, 1983.
To integrate the foreign gene into the genomic DNA of the plant cell, it is advantageous if the gene, consisting of structural gene and plant expression signals, is flanked by neutral DNA sequences carrier
DNA). The carrier DNA may consist of two linear DNA strands, so that the construction to be inserted into the plant cell is a linear DNA molecule. The DNA sequence prepared for the gene transformation can, however, also have an annular structure (plasmid structure). Such plasmids consist of a DNA strand into which the foreign gene containing the expression signals is integrated. The carrier DNA can be of synthetic origin or can be obtained from naturally occurring DNA sequences by treatment with suitable restriction enzymes.
Thus, for example, naturally occurring plasmids which have been opened with a selective restriction enzyme are suitable for use as carrier DNA.
Exemplary of such a plasmid is the readily obtainable pUC8 plasmid (described by Messing, J. and J.
Vieira, Gene 19,269-276, 1982). Fragments of naturally occurring plasmids can also be used as carrier DNA.
For example, the deletion mutant for gene VI of cauliflower mosaic virus can be used as carrier DNA.
The probability of the genetic transformation of a plant cell can be enhanced by different factors.
Accordingly, as is known from experiments with yeast, the number of successful stable gene transformations increases 1) with the increasing number of copies of the new genes per cell, 2) when a replication signal is combined with the new gene, and 3) when an integration signal is combined with the new gene.
The process of this invention is therefore susceptible of especially advantageous application when the transferred gene is combined with a replication signal which is effective in plant cells or with an integration signal which is effective in plant cells, or which is combined with both signals.
The expression of a gene in a plant cell depends on the transcription frequency of the gene in a messenger
RNA sequence. It is therefore advantageous if the new gene is combined with an enhancer signal that promotes this transcription. Methods meriting particular attention are those for transferring a gene which is combined with replication, integration and enhancer signals that are effective in plants.
It is further of great technical advantage if the transferred gene has a selective marker function, i.e. if the transformed plant cells can be separated from the non-transformed plant cells under specific conditions of selection. A marker function of this kind permits the process to be carried out efficiently in that only those plant cells need to be regenerated to calli or complete plants by microbiological techniques, the hereditary material of which plants contains a gene capable of expression that permits marker-specific methods of selection.
Whereas protoplasts, cell culture cells, cells in plant tissues, pollen, pollen tubes, egg-cells, embryo-sacs or zygotes and embryos in different stages of development are representative examples of plant cells which are suitable starting materials for a transformation, protoplasts are preferred on account of the possibility of using them direct without further pretreatments.
Isolated plant protoplasts, cells or tissues can be obtained by methods which are known per se or by methods analogous to known ones.
Isolated plant protoplasts which are also suitable starting materials for obtaining isolated cells and tissues can be obtained from any parts of the plant, for example from leaves, embryos, stems, blossoms, roots or pollen. It is preferred to use leaf protoplasts. The isolated protoplasts can also be obtained from cell cultures.
Methods of isolating protoplasts are described e.g. in Gamborg, O.L. and Wetter, L.R., Plant Tissue Culture methods, 1975,11-21.
The transfer of the new genes into plant cells is effected direct without using a natural system for infecting plants such as a plant bacterium, a plant virus, or transfer by insects or phytopathogenic fungi. This is achieved by treating the plant cells which it is desired to transform direct with the gene to be transferred by introducing the foreign gene and plant protoplasts into a suitable solution and leaving them therein until the foreign gene has been taken up by the protoplasts.The transformation frequency can be increased by combining this step with techniques which are employed in microbiological research for gene transfer, for example by treatment with poly-L-ornithine or poly-L-lysine, liposome fusion, DNA protein complexing, altering the charge at the protoplast membrane, fusion with microbial protoplasts, or calcium phosphate co-precipitation and, in particular, by treatment with polyethylene glycol, heat shock and electroporation, as well as a combination of these last three mentioned techniques.
Suitable solutions into which the foreign gene and the receptor protoplasts are introduced are preferably the osmotically stabilised culture media employed for protoplast cultures.
Numerous culture media are already available which differ in their individual components or groups of components. However, the composition of all media is in accordance with the following principle: they contain a group of inorganic ions in the concentration range from about 10 mole to several hundred mug/4 (so-called macroelements such as nitrate, phosphate, sulfate, potassium, magnesium, iron), a further group of inorganic ions in maximum concentrations of several mug/4 (so-called microelements such as cobalt, zinc, copper, manganese), then a number of vitamins (for example inositol, folic acid, thiamine), a source of energy and carbon, for example saccharose or glucose, and also growth regulators in the form of natural or synthetic phytohormones of the auxin and cytokinin classes in a concentration range from 0.01 to 10 mg/f.
The culture media are additionally stabilised osmotically with sugar alcohols (for example mannitol) or sugar (for example glucose) or salt ions (for example CaCI2), and are adjusted to a pH in the range from 5.6 to 6.5.
A more detailed description of conventional culture media will be found, for example, in Koblitz, H.,
Methodische Aspekte der Zell- und Gewebezuchtung bei Gramineen unter besonderer Berijcksichtigung der
Getreide, Kulturpflanze XXII, 1974,93-157.
A particularly suitable technique of gene transformation is "polyethylene glycol treatment", where the term "polyethylene glycol" within the scope of this invention denotes not only the substance polyethylene glycol itself, but will also be understood as generic term for all substances that likewise modify the protoplast membrane and are employed e.g. in the field of cell fusion.The term thus also comprises other polyhydric alcohols of longer chain length, for example polypropylene glycol (425 to 4000 g/mole), polyvinyl alcohol or polyhydric alcohols whose hydroxyl groups are partially or completely etherified, as well as the detergents which are commonly employed in agriculture and tolerated by plants, and which are described e.g. in the following publications:
"Mc Cutcheon's Detergents and Emulsifiers Annual"
MC Publishing Corp., Ridgewood New Jersey, 1981;
Stache, H., "Tensid-Taschenbuch",
Carl HanserVerlag, Munich/Vienna, 1981
If polyethylene glycol itself is used (as in Examples 1 to 3, 5 and 7), then it is preferred to use a polyethylene glycol having a molecular weight in the range from 1000 to 10,000 g/mole, preferably from 3000 to 8000 g/mole.
Of the above mentioned substances, it is preferred to use polyethylene glycol itself.
A substantial and reproducible transformation frequency of 10 5 is achieved by means of the techniques described above. However, this frequency can be greatly improved on by the appropriate techniques described in more detail hereinafter.
In the polyethylene glycol treatment, the procedure can be for example such that either a suspension of the protoplasts is added to a culture medium and then the gene, which is normally employed as plasmid, is added in a mixture of polyethylene glycol and culture medium, or, advantageously, protoplasts and gene (plasmid) are first added to the culture medium and then polyethylene glycol is added.
In the process of this invention, electroporation and heat shock treatment have also proved particularly advantageous techniques.
In electroporation [Neumann, E. et al., The EMBO Journal 7,841-845 (1982)], protoplasts are transferred to an osmoticum, for example a mannitol/magnesium solution and the protoplast suspension is introduced into the electroporator chamber between two electrodes. By discharging a condenser over the suspension, the protoplasts are subjected to an electrical impulse of high voltage and brief duration, thereby effecting polarisation of the protoplast membrane and opening of the pores in the membrane.
In the heat treatment, protoplasts are suspended in an osmoticum, for example a solution of mannitol/calcium chloride, and the suspension is heated in small containers for example centrifuge tubes, preferably in a water bath. The duration of heating will depend on the chosen temperature. In general, the values are in the range of 40 C for 1 hour and for 1 second. Optimum results are obtained at a temperature of 45"C over 5 minutes. The suspension is subsequently cooled to room temperature or lower.
It has also been found that the transformation frequency can be increased by inactivating the extracellular nucleases. Such an inactivation can be effected by using divalent cations that are tolerated by plants, for example magnesium or calcium, and also preferably by carrying out the transformation at a high pH value, with the optimum pH range being from 9 to 10.5.
Surprisingly, the selective use of these different methods results in the enormous increase in transformation frequency that has long been an objective in the field of genetic engineering.
The lower the transformation frequency in gene transformation, the more difficult and time-consuming it is to find the few cloned cells resulting from the transformed cells from among the enormous number of non-transformed clones. Where the transformation frequency is low, the use of conventional screening techniques is almost or completely impossible, unless the gene employed is one with selective marker function (e.g. resistance to a specific substance). Low transformation frequency thus requires a very substantial investment in time and effort when using genes without marker function.
In transformations using genes without marker function it is only possible to employ conventional screening techniques for finding cloned cells by selection efficiently and successfully if the transformation frequency is in the order of percentages (about 10.2). As will be shown below, the desired transformation frequency can now be achieved by means of the process of this invention. Surprisingly, the specific use of different techniques in the process of this invention results in an enormous increase in the previously attained transformation frequency up to 1 to 2%.
Combining foreign gene and receptor protoplasts before employing the other techniques such as polyethylene glycol treatment, electroporation and heat shock treatment brings about an improvement in transformation frequency of the order of about a power often as compared with a procedure in which the sequence of the steps employed is different.
Electroporation effects a 5-to 10-fold, and heat shock treatment a 10-fold or greater, improvement in transformation frequency.
A combination of two or three of the following techniques has proved advantageous: polyethylene glycol treatment, heat shock treatment and electroporation, with particularly good results being obtained by employing these techniques after the foreign gene and protoplasts have been introduced into a solution. The preferred technique is heat shock treatment before the polyethylene glycol treatment and the optional subsequent electroporation. In general, the additional electroporation effects a further increase in transformation frequency; but in some cases the results obtained by heat shock and polyethylene glycol treatment are no longer essentially improved by additional electroporation.
Just as the techniques can be combined with one another, so it is also possible to combine the use of divalent cations which are tolerated by plants andlor carrying out the transformation at pH 9 to 10.5 both with individual techniques, as well as combined techniques, preferably with polyethylene glycol treatment, heat shock treatment and electroporation. The numerous combination possibilities permitthe process of this invention to be adapted very well to the respective conditions.
The combination of heat shock treatment, polyethylene glycol treatment and, optionally, electroporation subsequent to the already existing combination of foreign gene and receptor protoplasts results in a transformation frequency of 1 of2 to 10-3.
Accordingly, the process of this invention permits a high transformation frequency to be achieved without utilising biological vectors for the transformation, for example cauliflower mosaic virus or Agrobacterium.
An advantageous method comprises for example transferring protoplasts to a mannitol solution and mixing the protoplast suspension so obtained with the aqueous solution of the gene. The protoplasts are then incubated in this mixture for 5 minutes at 45"C and subsequently cooled to 0 C over 10 seconds. Then polyethylene glycol (mol. wt. 3000 to 8000) is added until the concentration is in the range from 1 to 25%, preferably about 8%. After cautious thorough mixing, treatment is carried out in an electroporator. The protoplast suspension is then diluted with culture medium and the protoplasts are taken into culture.
The process of this invention is suitable for the transformation of all plants, especially those of the systematic groups Angiospermae and Gymnospermae.
Among the Gymnospermae, the plants of the Coniferae class are of particular interest.
Among the Angiospermae, plants of particular interest are, in addition to deciduous trees and shrubs, plants of the following families: Solanaceae, Cruciferae, Compositae, Liliaceae, Vitaceae, Chenopodiaceae,
Rutaceae, Bromeiiaceae, Rubiaceae, Theaceae, Musaceae or Gramineae and of the order Leguminosae, in particular of the family Papilionaceae. Preferred plants are representatives of the Solanaceae, Cruciferae and
Gramineae families.
To be particularly mentioned are plants of the species Nicotiana, Petunia, Hyoscyamus, Brassica und
Lolium, as for example, Nicotiana tabacum, Nicotiana plumbagenifolia, Petunia hybrida, Hyoscyamus muticus, Brassica napus, Brassica rapa and Lolium multiflorum.
In the field of transformation of plant cells, interest focuses in particular on the high yield cultivated plants such as maize, rice, wheat, barley, rye, oats and millet.
All plants which can be produced by regeneration from protoplasts can also be transformed utilising the process of this invention. So far it has not been possible to manipulate genetically representatives of the
Gramineae family (grasses), which also comprises cereals. It has now been shown that graminaceous cells, including cereal cells, can be transformed genetically by the above described method of direct gene transformation. In the same way, transformation of cultivated plants of the genus Solanum, Nicotiana,
Brassica, Beta, Pisum, Phaseolus, Glycine, Helianthus, Allium, wheat, barley, oat, Setaria, rape, rice,
Cydonia, Pyrus, Malus, Rebus, Fragaria, Prunus, Arachis, Secale, Panicum, Saccharum, Coffea, Camellia,
Musa, Ananas, Vitis or Citrus is possible and desirable, even if the total yields and crop areas are smaller worldwide.
The proof of transformed genes can be adduced in a manner known per se, for example by crossing analyses and molecular biological assays, including in particular the Southern blot analysis and enzyme activity tests.
The Southern blot analysis can be carried out for example as follows: the DNA isolated from the transformed cells or protoplasts is electrophoresed in 1% agarose gel after treatment with restriction enzymes and transferred to a nitrocellulose membrane [Southern, E.M., J. Mol. Biol. 98,503-517 (1975)], and hybridised with the DNA whose existence it is desired to establish and which was nick-translated [Rigby,
W.J., Dieckmann, M., Rhodes, C. and P. Berg. J. Mol. Biol. 113, 237- 51, (1977)] (DNA specific activity 5 x 108 to 10 x 108 c.p.mJg). The filters are washed 3 times for 1 hour with an aqueous solution of 0.03 M sodium citrate and 0.3 M sodium chloride at 65"C. The hybridised DNA is visualised by darkening an X-ray film for 24 to 48 hours.
Testing for enzyme activity - explained in more detail in the assay for aminoglycoside phosphotransferase (enzyme for kanamycin-specific phosphorylation) - can be carried out for example as follows: Callus or leaf pieces (100 to 200 mg) are homogenised in 20 (We of extraction buffer in an Eppendorf centrifuge tube. The buffer is modified from that used by Herrera-Estrella, L., DeBlock, M., Messens, E., Hernalsteens, J.-P., Van
Montagu, M. and J. Schell, EMBO J. 2,987-995 (1983) omitting bovine serum albumin and adding 0.1 M sucrose. The extracts are centrifuged for 5 minutes at 12000 g and bromophenol blue is added to the supernatant to a final concentration of 0.004%. The proteins in 35 > t of supernatant are separated by electrophoresis in a 10% non-denaturing polyacrylamide gel.The gel is covered with a layer of agarose gel containing kanamycin and y-32p labelled ATP, incubated, and the phosphorylated reaction products are transferred to Whatman p81 phosphocellulose paper. The paper is washed 6 times with deionised water at 90"C and then autoradiographed.
The following Examples illustrate the present invention in more detail but without limiting the scope thereof. They describe the construction of a hybrid gene and the insertion thereof in carrier DNA sequences of cyclic character, the transfer of said hybrid gene into plant cells, selection of the transformed plant cells and regeneration of complete plants from the transformed plant cells as well as the genetic crossing and molecular biological analysis thereof.
In the Examples, the process of the invention is illustrated as follows:
1) by transformation of tobacco plants by transfer of the NPT II gene by joining promoter and termination signals of the CaMV gene VI to the NPT II gene, inserting said gene into the pUC8 plasmid and transferring the resultant chimaeric plasmid into isolated tobacco protoplasts by polyethylene glycol treatment;;
2) by transformation of plants of the genus Brassica by transfer of the NPT II gene by joining promoter and termination signals of the CaMV gene VI to the NPT II gene, inserting this construction instead of the CaMV gene VI into the CaMV genome, and transferring the resultant chimaeric plasmid into isolated Brassica protoplasts by polyethylene glycol treatment, and
3) by transformation of plants of the genus Lolium by transfer of the NPT II gene by joining promoter and termination signals of the CaMV gene VI to the NPT II gene, inserting said gene into the pUC8 plasmid, and transferring the resultant chimaeric plasmid into isolated Lolium protoplasts by polyethylene glycol treatment.
Further, the advantageous effect on the transformation by heat shock treatment and electroporation as well as the combined method of heat shock treatment, polyethylene glycol treatment and electroporation after combining protoplasts and NPT II gene will be exemplified.
Example 1: Transformation of cells of Nicotiana tabacum c.v. Petit Havana SRI by transfer of the NPT ll gene a) Construction of the pABDlplasmid
The freely available plasmids pKm 21 and pKm 244 [Beck, E. et al., Gene 19,327-336(1982)] are cut with the
Pstl restriction endonuclease. The fragments of the plasmids which are used for recombination are purified by electrophoresis in 0.8% agarose gel. The plasmid pKm 21244 resulting from the combination of the fragments contains a combination of the 5'- and 3'-Bal 31 deletions of the NPT II gene, as described by Beck et al in Gene 19,327-336 (1982). Joining the promoter signal of cauliflower mosaic virus to the Hindlll fragment of the plasmid pKm 21244 is effected by constructing the linker plasmid pJPAX.The coupling plasmid pJPAX is obtained from the plasmids pUC8 and pUC9 [Messing, J. and J. Vieira, Gene 119,269-276 (1982)]. 10 base pairs of the linker sequence of the plasmid pUC9 are deleted by restriction at the Hindlll and
Sal I sites and the resultant cohesive ends are filled in by treatment with the polymerase I Klenow fragment [Jacobson, H. et al., Eur. J. Biochem. 45,623, (1974)] and ligating the polynucleotide chain, thus restoring the
Hindlll site. An 8 base pair synthetic Xhol linker is inserted at the Smal site of this deleted linker sequence.
Recombination of the appropriate Xorl and Hindlil fragments of the plasmid pUC8 and of the modified plasmid pUC9 yields the plasmid pJPAX with a partially asymmetric linker sequence containing the following sequence of restriction sites: EcoRI, SMal, BamHI, Sall, Psti, Hindlll, BamHI, Xhol and EcoRI.
Joining of the 5' expression signals of the CaMV gene VI and the Hindlll fragment of the NPT II gene is carried out on the plasmid pJPAX by inserting the promoter region of the CaMV VI gene between the Pstl and Hindlll sites. The plasmid so obtained is restricted at its single Hindlil site and the Hindlll fragment of the plasmid pKm 21244 is inserted into this restriction site in both orientations, yielding the plasmids pJPAX CaKm+ and pJPAX CaKm~. To provide an EcoRV site near the 3'-terminal region of the NPT II hybrid gene, a BamHI fragment of the plasmid pJPAX CaKm is inserted into the BamHI site of the plasmid pBR 327 [Soberon, X. et al., Gene 9, 287-305 (1980)], yielding the plasmid pBR 327 CaKm.The EcoRV fragment of the plasmid pBR 327
CaKm, which contains the new DNA construction, is used to replace the EcoRV region of the CaMV gene VI, which is cloned atthe Sall site in the plasmid pUC8,thereby placing the protein-coding DNA sequence of the
NPT II gene under the control of the 5' and 3' expression signals of the cauliflower mosaic gene VI. The plasmids so obtained are designated pABDI and pABDII respectively (q.v. Figure 1).
b) Transformation ofprotoplasts of Nicotiana tabacum c. v. Petit Havana SRI by transfer of the NPT gene as part of the plasmid pABDI by PEG treatment
Tobacco protoplasts at a population density of 2.106 per ml are suspended in 1 ml of K3 medium [q.v. Z.
Pflanzenphysiologie 78,453-455(1976); Mutation Research 81(1981)165-175], containing 0.1 mgle of 2,4-dichlorophenoxyacetic acid, 1.0 mg/f of 1-naphthylacetic acid and 0.2 mg/f of 6-benzylaminopurine, which protoplasts have been obtained beforehand from an enzyme suspension by flotation on 0.6 molar sucrose at pH 5.8 and subsequent sedimentation (100 g for 5 minutes) in 0,17 M calcium chloride at pH 5.8.
To this suspension are added, in succession, 0.5 ml of 40% polethylene glycol (PEG) with a molecular weight of 600 in modified (adjusted again to pH 5.8 after autoclaving) F-medium [Nature 296,72-74(1982)] and 56 le of an aqueous solution containing 15,lig of the plasmid pABDI and 50,us of calf thymus DNA. This mixture is cultured for 30 minutes at 26"C with occasional agitation and subsequent stepwise dilution with F medium.
The protoplasts are isolated by centrifuging (5 minutes at 100 g) and resuspended in 30 ml of fresh K3 medium. Further incubation is carried out in 10 ml portions in Petri dishes of 10 cm diameter at 24"C and in the dark. The population density is 6.3-104 protoplasts per ml. After 3 days the culture medium in each dish is diluted with 0.3 parts by volume of fresh K3 medium and incubated for a further 4 days at 24"C and 3000 lux.
After a total of 7 days, the clones developed from the protoplasts are embedded in a culture medium solidified with 1% of agarose and containing 50 mgtt of kanamycin, and cultured at 240C in the dark by the bead type culture method [Plant Cell Reports, 2,244-247 (1983)]. The culture medium is replaced every 5 days by fresh nutrient solution of the same kind.
c) Regeneration ofkanamycin-resistant tobacco plants
After 3 to 4 weeks of continued culturing in kanamycin-containing culture medium, the resistant calli of 2 to 3 mm diameter are transferred to agar-solidified LS culture medium [Physiol. Plant 18, 100-127 (1965)1, containing 0.05 mg/f of 2,4-dichlorophenoxyacetic acid, 2 mgff of 1-naphthylacetic acid, 0.1 mgle of 6-benzylaminopurine, 0.1 mg/t of kinetin and 75 mgK of kanamycin.Kanamycin-resistant Nicotiana tabacum Petit Havana SRI plants are obtained by inducing shoots on LS medium containing 150 mgle of kanamycin and 0.2 mug/6 of 6-benzylaminopurine, and subsequent rooting on Tedium [Science 163,85-87 (1969)].
d) Detection of the NPT Il gene in hereditary material of plants
Samples of 0.5 g of callus of the transformed cell cultures or leaf tissue of the plants regenerated therefrom are homogenised at 0 C in 15% saccharose solution containing 50 mmol/t of 1 -ethylenediamine
N,N,N',N'-tetraacetic acid (EDTA), 0.25 molK of sodium chloride and 50 mmol/f of,a- tris(hydroxymethyl )methylamine hydrochloride (TRIS-HCI) at pH 8. Centrifugation of the homogenate for 5 minutes at 1000 g gives a crude nuclear pellet which is resuspended at pH 8.0 in 15% saccharose solution containing 50 mmol/'f of EDTA and 50 mmol/f of TRIS-HCI.Sodium dodecyl sulfate is added to a final concentration of 0.2% and heated for 10 minutes to 70"C. After cooling to 20s250C, potasasium acetate is added to the mixture to a concentration of 0.5 molls This mixture is incubated for 1 hour at 0 C. The precipitate is centrifuged for 15 minutes at 4"C in a microcentrifuge. The DNA is precipitated from the supernatant with 2.5 volumes of ethanol at 200-250C. The isolated DNA is dissolved in a solution of 10 mmol of TRIS-HCI containing 10 ILg/ml of ribonuclease A. After incubation for 10 minutes at 37"C, proteinase K is added to a concentration of 250 Ig/ml and incubation is continued for 1 hour at 37"C. The proteinase K is removed by phenol and chloroform/ isoamyl alcohol extractions. The DNA is precipitated from the aqueous phase by addition of 0.6 part by volume of a 0.6 molar solution of sodium acetate in isopropanol and dissolved in 50 Ae of a solution containing 10 mmol/f of TRIS-HCI and 5 mmol/f of EDTA at pH 7.5. This preparation yields DNA sequences which contain substantially more than 50,000 base pairs.Restriction of the DNA with EcoRV endonuclease, hybridisation of the fragments with radioactively labelled Hindlll fragments of the NPT II gene and comparison with the plasmid pABDI show, in Southern blot analysis, the presence of the NPT II gene in the cell nucleus DNA of the transformed Nicotiana tabacum cells.
e) Evidence of the transfer of the trans formed gene to sexual offspring and of its heredity as normal plant gene
Extensive genetic crossing analyses and detailed molecular biological studies (for example Southern blot analysis of the DNA of the plant genome; investigation of the enzyme activity of the aminoglycoside phosphotransferase, i.e. the enzyme for the kanamycin-specific phosphorylation) with the genetically transformed plants (first generation and progeny) have yielded the following results: 1. the baceterial gene is stably integrated into the plant genome; 2. it is normally unchanged and regularly transferred to crossed progeny; 3. its heredity corresponds to that of a natural, simple dominant plant gene; 4. the molecular analysis by DNA hybridisation and enzyme test confirms the results of the genetic crossing analysis; 5. the genetically transformed plants retain their normal, natural phenotype during the treatment, i.e. no undesirable modifications are observed.
These results show that the process of this invention for the direct transfer of a gene into protoplasts affords the best mode of specifically transforming plant material genetically. The genetic transformation is stable and unwanted modifications in the genotype of the plant do not occur. Parallel results are also obtained when carrying out the transformation described in the foregoing Example with Nicotiana plumbagenifolia, Petunia hybrida, Hyoscyamus muticus and Brassica napus.
Example 2: Transformation of cells of Brassica rapa cv. Just Right by transfer ofthe NPTll gene a) Construction of the plasmidpCaMV6Km The plasmid pBR 327 Cm am described in Example 1 a is digested with restriction endonuclease EcoRV and the EcoRV restriction fragment containing the kanamycin-resistant gene (NPT II) is used to replace the
EcoRV fragment of the plasmid pCa20-Bal I, which fragment contains the gene VI of cauliflower mosaic virus, yielding the plasmid pCaMV6Km (Figure 2). The plasmid Ca20-Bal I is a chimaeric CaMV plasmid which is derived from the natural deletion mutant CM4-184. The entire region II is missing from this plasmid, except for the first 5 codons and the translation stop signal TGA. An Xhol coupling component was inserted immediately before the stop codon in region II.
b) Transformation ofprotoplasts of Brassica rapa cv. Just Right by transfer ofthe NPTgene as part of the plasmid pCaMV6Km by PEG treatment
Brassica rapa protoplasts are washed with a suitable osmoticum and suspended in a population density of 5.106 per ml in a culture medium prepared according to Protoplasts 83, Proceedings Experientia
Supplementum, Birkhäuser Verlag, Basel, Vol.45(1983), 44-45. 40% polyethylene glycol (PEG) with a molecular weight of 6000, dissolved in modified F medium (pH 5.8) (q.v. Example 1 b), is mixed with the protoplast suspension to a final concentration of 13% PEG.To this mixture is added immediately a solution of 10 elm of plasmid pCaMV6Km digested with endonuclease Sal I, and 50 g of calf thymus DNA in 60 > 9 of water. With occasional agitation, the mixture is incubated for 30 minutes at 20 -25 C. Then 3 x 2 ml of modified F medium (6 ml in all) and 2 x 2 ml of culture medium (4 ml in all) are added at 5 minute intervals.
The protoplast suspension is transferred to 10 cm Petri dishes and made up to a total volume of 20 ml with additional culture medium. These protoplast suspensions are incubated in the dark for 45 minutes at 26"C.
The protoplasts are isolated by sedimentation for 5 minutes at 100 g, taken up in an initially liquid and then solidifying agarose gel culture medium and cultured by the bead type culture method [Plant Cell Reports 2, 244-247 (1983)]. After 4 days, in the development stage of the first cell division, kanamycin is added to the cultures in a concentration of 50 mg/f. The liquid culture medium surrounding the agarose segments is replaced every 4 days by fresh kanamycin-containing nutrient solution. After 4 weeks the kanamycinresistant clones are isolated and then further cultured by providing them weekly with kanamycin-containing nutrient solution (50 mole).
c) Detection of the NPT Il gene in the hereditary material of the plants
The presence of the NPT II gene in the cell nucleus of the transformed Brassica rapa cells can be detected by isolation of the cell nucleus DNA and restriction thereof and hybridisation of the DNA fragments as described in Example 1 d).
Example 3: Transformation ofprotoplasts of graminaceous plants of the species Lolium multiflorum
Protoplasts of Lolium multiflorum (Italian ryegrass) are taken up at a concentration of 2-106 per ml in 1 ml of 0.4 molar mannitol at pH 5.8. To this suspension are added, in succession, 0.5 ml of 40% polyethylene glycol (PEG) with a molecular weight of 6000 in modified (pH 5.8) F medium [Nature 296,72-74(1982)], and 65 Ff of an aqueous solution containing 15 ijg of the plasmid pABDI and 50 CLg of calf thymus DNA. This mixture is incubated for 30 minutes at 26"C with occasional agitation and subsequently diluted with F medium, as described in Nature 296(1982), 72-74.The protoplasts are isolated by centrifugation (5 minutes at 100 g) and taken up in 4 ml of CC culture medium [Potrykus, Harms, Lore, Callus formation from cell culture protoplasts of corn (Zea Mays L.), Theor. Appl. Genet. 54, 209-214 (1979)1 and and incubated in the dark at 24"C. After 14 days the developing cell cultures are transferred to the same culture medium, but with the the antibiotic G-418 (commercially available; GIBCO EUROPE Product Catalogue, Catalogue No. 0661811). G-418 is toxic to Lolium cells at a concentration of 25 mg/t and permits solely the further development of cells which have taken up the bacterial gene for kanamycin resistance.G-418 is a kanamycin analog with substantially better activity in graminaceous cells than kanamycin itself. Resistant cell colonies are transferred to agar medium (the same medium as above, 25 ml/( G-418, without osmoticum) and, after reaching a size of several grams fresh weight per cell colony, analysed for the presence of the bacterial gene and for the biological activity of the gene. The former analysis is made by hybridisation of a radioactively labelled DNA sample of the gene with DNA which has been isolated from the cell culture; while the latter is made by detecting the enzyme activity by phosphorylation of kanamycin with radioactive ATP.Both molecular analyses yielded unequivocal proof of the genetic transformation of the cell colonies which had been selected on G-418. The assays constitute the first proof of the genetic transformation of protoplasts of graminaceous plants and furthermore prove that, in principle, protoplasts of grasses can be genetically manipulated by the described process. The possibilities of genetically manipulating cultivated grasses, for example cereals, is thus also afforded.
Example 4: Transformation of cell culture cells of Nicotiana tabacum by transferring the NPTgene by means of electroporation
Protoplasts are produced by sedimentation from 50 ml of a log phase suspension culture of the nitrate reductase deficiency variant of Nicotiana tabacum, cell strain nia-1 15 [Muller, A.J. and R. Grafe, Mol. Gen.
Genet. 161, 67-76 (1978)], and resuspended in 20 ml of enzyme solution [2% Cellulase Onozuka R-10,1% Mazerozym R-10 and 0.5 % Driselase (available from Chemische Fabrik Schweizerhalle, Basel) in a wash solution (0.3 M mannitol, 0.04 M calcium chloride and 0.5 %2-(N-morpholino)ethanesulfonic acid), adjusted to pH 5.6 with KOH] and incubated for 3 hours on a gyratory shaker at 24 C. The protoplasts are then separated from undigested tissue by filtering them through a 100 m mesh sieve. An equal volume of 0.6 M sucrose is added and the suspension is centrifuged for 10 minutes at 100 g. The protoplasts floating on the surface are collected and washed 3 times by sedimentation in the wash solution.
Transformation is carried out by electroporation. The chamber of a DialogR "Porator" (available from
Dialog GmbH, Harffstr. 34,4000 Dusseldorf, West Germany) is sterilised by washing with 70% ethanol and then 100% ethanol and dried by a current of sterile air from a ventilator with laminary air flow). The protoplasts are suspended at a concentration of 1 x 105/ml in 0.4 M mannitol solution, adjusted with magnesium chloride to a resistance of 1.4 kOhm and pABDI DNA is added in a concentration of 10 Fg/ml.
0.38 ml samples of this protoplast suspension are subjected 3 times at 10 second intervals to a charge of 1000 volts or to a charge of 2000 volts. The protoplasts are then cultured in a concentration of 1 x 105/my in 3 ml of AA-CH medium [AA medium of Glimelius, K. et al., Physiol. Plant. 44,273-277 (1978)], modified by increasing the inositol concentration to 100 mglf and the saccharose concentration to 34 git, as well as by adding 0.05 ml/e of 2-(3-methyl-2-butenyl)adenine, and which is solidified by a 0.6% content of agarose (Sea
Plaque, FMC Corp., Marine Colloids Division, P.O. Box 308, Rockland, Maine 04841, USA).
After 1 week, the agarose layer containing the protoplasts is transferred to 30 ml of liquid AA-CH medium which contains 50 mg/f of kanamycin. After 3 weeks, during which time half the liquid medium is replaced weekly by fresh medium of the same composition, the transformed cell colonies can be observed visually.
Four weeks after being transferred to the medium containing kanamycin, these cell colonies are transferred to AA medium (Glimelius, K. et al., Physiol. Plant. 44,273-277 (1978); 0.8% agar), which contains 50 mglf of kanamycin, for further culturing and investigation. Confirmation of the successful transformation is by DNA hybridisation and testing for the enzyme activity of aminoglycoside phosphotransferase,
Analogous assays with protoplasts of Brassica rapa and Lolium multiflorum also result in successful transformations.
Example 5: Transformation of cells of Nicotiana tabacum by transfer of the NPTllgene by electroporation
The preparation of the electroporator is as described in Example 4 and of the protoplasts as in Example 1.
For transformation, protoplasts of Nicotiana tabacum are resuspended in a concentration of 1.6 x 106/ml in mannitol solution (0.4 M, buffered with 0.5% w/v of 2-(N-morpholino)ethanesulfonic acid; pH pH 5.6). The resistance of the protoplast suspension is measured in the porator chamber (0.38 ml) and adjusted to 1 to 1.2 kOhm with magnesium chloride solution (0.3 M). 0.5 ml samples are put into capped plastic tubes (5 ml volume) to each of which are added initially 40 ijf of water containing 8 yg of pABDI (linearised with Smal) and 20 p9 of calf thymus DNA, and then 0.25 ml of polyethylene glycol solution (24% w/v in 0.4 M mannitoi).
Nine minutes after addition of the DNA, 0.38 ml portions are put into the pulse chamber and 10 minutes after the addition of DNA, the protoplast suspensions present in the chamber are subjected to 3 impulses (1000-2000 volts) at 10 second intervals. The treated portions are put into Petri dishes of 6 cm diameter and kept for 10 minutes at 20"C. Then 3 ml of K3 medium containing 0.7% w/v of Sea Plaque agarose are added to each Petri dish and the contents of the dish are thoroughly mixed. Ater solidification of the contents of each dish, the cultures are kept for 1 day at 24"C in the dark and then for 6 days in light. The protoplast-containing agarose is then cut into quarters and introduced into liquid medium. The protoplasts are then cultured by the bead type culturing method.Callus tissues which are obtained by selection of the transformed material with kanamycin and plants regenerated therefrom contain the NPT II enzyme (aminoglycoside phosphotransferase) as product of the NPT II gene.
Electroporation induces a 5-to 10-fold increase in the frequency of transformation compared with the method without electroporation. Analogous assays with Brassica rapa c.v. Just Right and Lolium multiflorum also bring about an increase in the frequency of transformation of the same order of magnitude.
Example 6: Transformation of cells of Nicotiana tabacum by transfer of the NPTllgene by means of heat shock
Protoplasts isolated from leaves or cell cultures of Nicotiana tabacum are isolated as described in
Examples 1 and 4 and transferred to an osmotic medium as described in the preceding Examples. The protoplast suspensions are kept for 5 minutes at 45"C, cooled with ice for 10 seconds and then the plasmid pABDI is added as described in Examples 1 and 4. The heat shock treatment increases the transformation frequency by a factor of 10 or higher compared with a transformation carried out without this treatment.
Analogous assays with the protoplasts and plasmids described in Examples 2 and 3 also bring about an increase in the frequency of transformation of the same order of magnitude.
Example 7: Transformation of different plant cells by transfer of the NPTllgene by combining protoplasts and gene as first step and subsequent combined treatment
Protoplasts ofthe plants:
Nicotiana tabacum c.v. Petit Havana SRI (A),
Brassica rapa c.v. Just Right (B) and
Lolium multiflorum (C)
are isolated and transferred to an osmotic medium as described in Example 5. The protoplast suspensions of A) and C) are mixed with the plasmid pABDI (Example 1a), and those of B) with the plasmid pCaMV6Km (Example 2a) as described in Examples 1 to 3, but without simultaneous treatment with polyethylene glycol.
The protoplast suspensions are then subjected to a heat shock treatment as described in Example 6, then to a polyethylene glycol treatment as described in Examples 1 to 3, and finally subjected to electroporation as described in Example 5. The transformation frequency in this procedure is in the range from 1 3 to 1 of2, but may be from 1 to 2% depending on the conditions. (The transformation frequency in Examples 1 to 3 is in the order of about 10-5). Results in the range from 1 10-3to to 10.2 are also obtained if, after combining protoplasts and plasmids, the subsequent steps of heat shock, polyethylene glycol treatment and electroporation are employed in different sequence.
Claims (33)
1. A process for the transformation of hereditary materials of plants, which comprises transferring a gene, which is under the control of plant expression signals, direct into plant cells without the aid of natural systems for infecting plants.
2. A process according to claim 1 for the vector-free transformation of plant genes, which comprises introducing a foreign gene for insertion and plant protoplasts which act as recipients together into a suitable solution and leaving them therein until the gene has been taken up by the protoplasts.
3. A process according to claim 2, wherein an osmotically stabilised protoplast culture medium is employed as solution.
4. A process according to claim 2, wherein foreign gene and protoplasts are left in the solution for a period of time extending from several seconds to several hours.
5. A process according to claim 1, which comprises using a gene whose structural part is of plant, animal, microbial, viral or synthetic origin and whose expression signals are of plant, animal or synthetic origin.
6. A process according to claim 1, wherein the gene is combined with a plant replication signal.
7. A process according to claim 1, wherein the gene is combined with a plant integration signal.
8. A process according to claim 1, wherein the gene is combined with a plant replication signal and a plant integration signal.
9. A process according to claim 1, wherein the gene is combined with an enhancer sequence.
10. A process according to claim 1, wherein the gene is combined with a plant replication signal and an enhance sequence.
11. A process according to claim 1, wherein the gene is combined with a plant integration signal and an enhancer sequence.
12. A process according to claim 1, wherein the gene is combined with a plant replication signal, a plant integration signal and an enhancer sequence.
13. A process according to claim 1, wherein the gene transfer is carried out by a technique which is known per se selected from polyethylene glycol treatment, poly-L-ornithine or poly-L-lysine treatment, liposome fusion, electroporation, combined incubation of gene and plant cell, DNA protein complexing,
charge modification at the protoplast membrane, fusion with microbial protoplasts, calcium phosphate
co-precipitation or heat shock treatment.
14. A process according to claim 1, wherein the gene transfer is carried out by a technique which is
known per se selected from polyethylene glycol treatment, poly-L-ornithine or poly-L-lysine treatment,
liposome fusion, electroporation, combined incubation of gene and plant cell, DNA protein complexing, charge modification at the protoplast membrane, fusion with microbial protoplasts or calcium phosphate co-precipitation.
15. A process according to claim 14, wherein the gene transfer is carried out by polyethylene glycol treatment.
16. A process according to claim 13, wherein the gene transfer is carried out by heat shock treatment.
17. A process according to claim 14, wherein the gene transfer is carried out by electroporation.
18. A process according to claim 13, wherein the gene transfer is carried out by a combination of two or three of the techniques comprising polyethylene glycol treatment, heat shock treatment and electroporation.
19. A process according to claim 18, wherein the gene transfer is carried out by a combination of two or three of the techniques comprising polyethylene glycol treatment, heat shock treatment and electroporation, which technique is employed after introducing the foreign gene and the protoplasts into a solution.
20. A process according to claim 19, wherein the gene transfer is carried out by introducing the foreign gene and the protoplasts into a solution and subsequently subjecting the resultant suspension first to heat shock treatment and then to treatment with polyethylene glycol.
21. A process according to claim 19, wherein the gene transfer is carried out by introducing the foreign gene and the protoplasts into a solution and subjecting the resultant suspension first to heat shock treatment, then to treatment with polyethylene glycol and, finally, to electroporation.
22. A process according to claim 1, wherein the gene transfer is carried out in the presence of divalent cations which are tolerated by plants.
23. A process according to claim 22, wherein the cations are magnesium or calcium cations.
24. A process according to claim 1, wherein the gene transfer is carried out at pH of 9 to 10.5.
25. A process according to claim 1, wherein the protoplasts are protoplasts of plants of the Solanaceae,
Cruciferae, Compositae, Liliaceae, Vitaceae, Chenopodiaceae, Rutaceae, Bromeliaceae, Rubiaceae,
Theaceae, Musaceae or Gramineae families or of the order Leguminosae.
26. A process according to claim 25, wherein the protoplasts are protoplasts of plants of the Solanaceae,
Cruciferae and Gramineae families.
27. A process according to claim 1 for the transformation of plants which can be regenerated from protoplasts.
28. A process according to claim 1 for the transformation of plants selected from the group consisting of
Nicotiana tabacum, Nicotiana plumbagenifolia, Petunia hybrida, Hyoscyamus muticus and Brassica napus by transfer of the NPT II gene, which process comprises joining promoter and termination signals of the
CaMV gene VI to the NPT II gene, inserting said gene into the pCU8 plasmid, and transferring the resultant chimaeric plasmid by polyethylene glycol treatment into isolated protoplasts of plants of the aforementioned group.
29. A process according to claim 28 forthe the transformation of tobacco plants by transfer of the NPT II gene, which comprises joining promoter and termination signals of the CaMV gene VI to the NPT II gene, inserting said gene into the pUC8 plasmid and transferring the resultant chimaeric plasmid into isolated tobacco protoplasts by treatment with polyethylene glycol.
30. A process according to claim 1 for the transformation of plants of the genus Brassica by transfer of the NPT II gene, which comprises joining promoter and termination signals of the CaMV gene VI to the NPT II gene, inserting this construction instead of the CaMV gene VI into the CaMV genome, and transferring the resultant chimaeric plasmid into insolated Brassica protoplasts by treatment with polyethylene glycol.
31. A process according to claim 1 for the transformation of plants of the genus Lolium by transfer of the
NPT II gene, which process comprises joining promoter and termination signals of the CaMV gene VI to the
NPT II gene, inserting said gene into the pUC8 plasmid, and transferring the resultant chimaeric plasmid into isolated Lolium protoplasts by treatment with polyethylene glycol.
32. Plant protoplasts obtainable by the process as claimed in claim 1 and plant material derived therefrom.
33. Plants which have been regenerated from protoplasts treated according to claim land the sexual and somatic progeny thereof.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH233684 | 1984-05-11 | ||
| CH60685 | 1985-02-11 | ||
| CH139885 | 1985-04-01 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8511630D0 GB8511630D0 (en) | 1985-06-12 |
| GB2159173A true GB2159173A (en) | 1985-11-27 |
| GB2159173B GB2159173B (en) | 1988-10-12 |
Family
ID=27172240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08511630A Expired GB2159173B (en) | 1984-05-11 | 1985-05-08 | Transformation of hereditary material of plants |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP0164575B1 (en) |
| JP (2) | JP3038479B2 (en) |
| AR (1) | AR243933A1 (en) |
| AT (2) | ATE204017T1 (en) |
| AU (1) | AU600221B2 (en) |
| BR (1) | BR8502223A (en) |
| CA (1) | CA1341471C (en) |
| DD (1) | DD242425A5 (en) |
| DE (2) | DE3585638D1 (en) |
| GB (1) | GB2159173B (en) |
| HU (1) | HUT40163A (en) |
| IL (1) | IL75145A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2183660A (en) * | 1985-11-22 | 1987-06-10 | Ciba Geigy Ag | Direct insertion of DNA into plastids and mitochondria |
| WO1988003564A1 (en) * | 1986-11-03 | 1988-05-19 | Biotechnica International, Inc. | Plant transformation |
| US5484956A (en) * | 1990-01-22 | 1996-01-16 | Dekalb Genetics Corporation | Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin |
| US5489520A (en) * | 1990-04-17 | 1996-02-06 | Dekalb Genetics Corporation | Process of producing fertile transgenic zea mays plants and progeny comprising a gene encoding phosphinothricin acetyl transferase |
| US5508184A (en) * | 1986-12-05 | 1996-04-16 | Ciba-Geigy Corporation | Process for transforming plant protoplast |
| US5508468A (en) * | 1990-01-22 | 1996-04-16 | Dekalb Genetics Corporation | Fertile transgenic corn plants |
| US5750871A (en) * | 1986-05-29 | 1998-05-12 | Calgene, Inc. | Transformation and foreign gene expression in Brassica species |
| US5780709A (en) * | 1993-08-25 | 1998-07-14 | Dekalb Genetics Corporation | Transgenic maize with increased mannitol content |
| US6399861B1 (en) | 1990-04-17 | 2002-06-04 | Dekalb Genetics Corp. | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US6803499B1 (en) | 1989-08-09 | 2004-10-12 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US6946587B1 (en) | 1990-01-22 | 2005-09-20 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE74162T1 (en) * | 1983-08-04 | 1992-04-15 | Ciba Geigy Ag | METHODS FOR MAINTAINING AND PROPAGATING DEFECTIVE, NON-INFECTIOUS VIRUS GENOMES. |
| US5215903A (en) * | 1983-08-04 | 1993-06-01 | Ciba-Geigy Corporation | Process for the maintenance and proliferation of defective non-infectious virus genomes in proliferating plant materials |
| GB8601680D0 (en) * | 1986-01-23 | 1986-02-26 | Agricultural Genetics Co | Modification of plant viruses |
| IL84459A (en) * | 1986-12-05 | 1993-07-08 | Agracetus | Apparatus and method for the injection of carrier particles carrying genetic material into living cells |
| US5120657A (en) * | 1986-12-05 | 1992-06-09 | Agracetus, Inc. | Apparatus for genetic transformation |
| IL82153A (en) * | 1987-04-09 | 1991-12-15 | Yissum Res Dev Co | Process for introducing genes into plants |
| JPS63287485A (en) * | 1987-05-19 | 1988-11-24 | Norin Suisansyo Nogyo Seibutsu Shigen Kenkyusho | Method for transforming monocotyledonous plant |
| ES2074999T3 (en) * | 1987-05-20 | 1995-10-01 | Ciba Geigy Ag | ZEA MAYS PLANTS AND TRANSGENIC PLANTS REGENERATED FROM PROTOPLASTS OR CELLS DERIVED FROM PROTOPLASTS. |
| US5350689A (en) * | 1987-05-20 | 1994-09-27 | Ciba-Geigy Corporation | Zea mays plants and transgenic Zea mays plants regenerated from protoplasts or protoplast-derived cells |
| EP0362244B1 (en) * | 1987-05-22 | 1994-04-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Embryos of useful plants as uptake system for exogeneous genetic information |
| CA1327173C (en) * | 1987-07-21 | 1994-02-22 | Erwin Heberle-Bors | Method of gene transfer into plants |
| EP0360750A3 (en) * | 1988-09-22 | 1991-01-02 | Ciba-Geigy Ag | Novel herbicide tolerant plants |
| US6329574B1 (en) | 1990-01-22 | 2001-12-11 | Dekalb Genetics Corporation | High lysine fertile transgenic corn plants |
| US6025545A (en) | 1990-01-22 | 2000-02-15 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US6777589B1 (en) | 1990-01-22 | 2004-08-17 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US5149655A (en) * | 1990-06-21 | 1992-09-22 | Agracetus, Inc. | Apparatus for genetic transformation |
| US6395966B1 (en) | 1990-08-09 | 2002-05-28 | Dekalb Genetics Corp. | Fertile transgenic maize plants containing a gene encoding the pat protein |
| US6326527B1 (en) | 1993-08-25 | 2001-12-04 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
| US6118047A (en) | 1993-08-25 | 2000-09-12 | Dekalb Genetic Corporation | Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction |
| WO1999014331A2 (en) | 1997-09-16 | 1999-03-25 | Cropdesign Nv | Cyclin-dependent kinase inhibitors and uses thereof |
| DE69838939T2 (en) | 1997-09-19 | 2008-04-30 | Nissan Motor Co., Ltd., Yokohama | DEVICE FOR PROTECTING THE OCCUPANCY OF A VEHICLE ON A SIDE IMPACT |
| JP3365271B2 (en) | 1997-09-19 | 2003-01-08 | 日産自動車株式会社 | Airbag device for automobile side collision |
| ATE537257T1 (en) | 1998-06-02 | 2011-12-15 | Univ Nihon | DNA ASSOCIATED WITH IGA NEPHROPATHY |
| EP2336337B1 (en) | 1998-11-12 | 2015-07-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Chimeric promoters capable of mediating gene expression in plants upon pathogen infection and uses thereof |
| JP4623825B2 (en) | 1999-12-16 | 2011-02-02 | 協和発酵バイオ株式会社 | Novel polynucleotide |
| CA2953239A1 (en) | 2000-10-06 | 2002-04-18 | Kyowa Hakko Kirin Co., Ltd. | Antibody composition-producing cell |
| SG135907A1 (en) | 2001-03-15 | 2007-10-29 | Sumitomo Chemical Co | Analysis of agonist-activity and antagonist-activity to cytokinin receptor |
| EP1925672A1 (en) | 2001-06-22 | 2008-05-28 | Syngeta Participations AG | Abiotic stress responsive polynucleotides and polypeptides |
| BR122014018568B1 (en) | 2001-10-19 | 2015-12-01 | Sumitomo Chemical Co | methods for giving a plant herbicide resistance, weed control, as well as evaluating a cell or plant's resistance to a herbicide compound |
| CA2497338A1 (en) | 2002-08-30 | 2004-03-18 | Japan Science And Technology Corporation | Method of targeted gene disruption, genome of hyperthermostable bacterium and genome chip using the same |
| WO2004058960A1 (en) | 2002-12-26 | 2004-07-15 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing dipeptide |
| JP2004243976A (en) | 2003-02-17 | 2004-09-02 | Takata Corp | Airbag device for side impact |
| WO2004081184A2 (en) | 2003-03-07 | 2004-09-23 | Seminis Vegetable Seeds, Inc. | Markerless transformation |
| ES2339559T3 (en) | 2003-12-16 | 2010-05-21 | Pioneer Hi-Bred International, Inc. | SUPPRESSION TRANSGERS OF DOMINANT GENE AND METHODS OF USE OF THE SAME. |
| US20070169227A1 (en) | 2003-12-16 | 2007-07-19 | Pioneer Hi-Bred International Inc. | Dominant Gene Suppression Transgenes and Methods of Using Same |
| NZ552259A (en) | 2004-07-08 | 2008-09-26 | Dlf Trifolium As | Means and methods for controlling flowering in plants |
| EP1930344A4 (en) | 2005-09-29 | 2008-12-31 | Shionogi & Co | Polypeptide having anti-angiogenic activity |
| EP2011870A4 (en) | 2006-04-14 | 2010-09-15 | Medical & Biol Lab Co Ltd | Mutant polypeptide having effector function |
| DE602007012269D1 (en) | 2006-08-31 | 2011-03-10 | Monsanto Technology Llc | PROCESS FOR PRODUCING TRANSGENIC PLANTS |
| WO2008038613A1 (en) | 2006-09-25 | 2008-04-03 | Kyowa Hakko Bio Co., Ltd. | Method for production of dipeptide |
| US20110236374A1 (en) | 2007-01-24 | 2011-09-29 | Kyowa Hakko Kirin Co., Ltd. | Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2 |
| AU2008208288B2 (en) | 2007-01-24 | 2014-04-03 | Kyowa Kirin Co., Ltd. | Genetically recombinant antibody composition having enhanced effector activity |
| EP2123751A4 (en) | 2007-01-25 | 2010-06-02 | Kyowa Hakko Kirin Co Ltd | NEW PEPTIDE |
| JP5550041B2 (en) | 2007-09-27 | 2014-07-16 | 塩野義製薬株式会社 | Method for producing adamantane hydroxide using cytochrome P450 |
| JP5620106B2 (en) | 2007-10-24 | 2014-11-05 | 株式会社糖鎖工学研究所 | Polypeptide having enhanced effector function |
| EP2311864A4 (en) | 2008-08-13 | 2013-07-31 | Kyowa Hakko Kirin Co Ltd | Recombinant protein-s composition |
| US8304249B2 (en) | 2008-10-09 | 2012-11-06 | Kyowa Medex Co., Ltd. | Fructosyl peptide oxidase |
| EP2184351A1 (en) | 2008-10-30 | 2010-05-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Polynucleotides encoding caryophyllene synthase and uses thereof |
| ES2602971T3 (en) | 2010-03-02 | 2017-02-23 | Kyowa Hakko Kirin Co., Ltd. | Modified Antibody Composition |
| WO2011118739A1 (en) | 2010-03-26 | 2011-09-29 | 協和発酵キリン株式会社 | Novel antibody having modification site introduced therein, and antibody fragment |
| JP5058332B2 (en) | 2010-07-14 | 2012-10-24 | 住友ゴム工業株式会社 | Isoprene oligomer, polyisoprene, and production methods thereof, rubber composition, and pneumatic tire |
| JP5932832B2 (en) * | 2010-12-17 | 2016-06-08 | モンサント テクノロジー エルエルシー | Methods for improving plant cell eligibility |
| WO2014127835A1 (en) | 2013-02-22 | 2014-08-28 | Christian-Albrechts-Universität Zu Kiel | Plant-derived resistance gene |
| WO2015005258A1 (en) | 2013-07-09 | 2015-01-15 | 協和メデックス株式会社 | Glycated hexapeptide oxidase and use thereof |
| JP6448194B2 (en) | 2014-01-20 | 2019-01-09 | 住友ゴム工業株式会社 | By introducing a gene encoding cis-prenyltransferase and a gene encoding NogoBreceptor into the host, the transformant in which the cis-prenyltransferase and NogoBreceptor were expressed in the host, and the transformant were used. Method for producing polyisoprenoid |
| JP6719174B2 (en) | 2015-02-23 | 2020-07-08 | 住友ゴム工業株式会社 | A vector containing a specific promoter and a gene encoding a specific protein, a transformed plant into which the vector is introduced, and a method for improving the production amount of polyisoprenoid by introducing the vector into the plant |
| JP6557989B2 (en) | 2015-02-23 | 2019-08-14 | 住友ゴム工業株式会社 | Vector containing gene encoding specific promoter and specific protein, transformed plant introduced with the vector, and method for improving polyisoprenoid production by introducing the vector into the plant |
| JP6557990B2 (en) | 2015-02-23 | 2019-08-14 | 住友ゴム工業株式会社 | Vector containing gene encoding specific promoter and specific protein, transformed plant introduced with the vector, and method for improving polyisoprenoid production by introducing the vector into the plant |
| MX2019008221A (en) | 2017-01-10 | 2019-12-09 | Univ Yamaguchi | ANTI-GPC3 ANTIBODY. |
| JP2020195326A (en) | 2019-06-03 | 2020-12-10 | 住友ゴム工業株式会社 | Manufacturing method of natural rubber, transformed plant, manufacturing method of pneumatic tire and manufacturing method of rubber products |
| JP6923166B2 (en) | 2019-07-16 | 2021-08-18 | 住友ゴム工業株式会社 | Fusion protein, substance manufacturing method, vector, transformed cell, pneumatic tire manufacturing method and rubber product manufacturing method |
| JP2021080204A (en) | 2019-11-19 | 2021-05-27 | 住友ゴム工業株式会社 | Fusion proteins, methods for producing substance, vectors, transformed cells, methods for manufacturing pneumatic tires, and methods for manufacturing rubber products |
| WO2021177074A1 (en) | 2020-03-05 | 2021-09-10 | 住友ゴム工業株式会社 | Method for producing polyisoprenoid, vector, transformed plant, method for producing pneumatic tire, and method for producing rubber product |
| JP7829849B2 (en) | 2021-09-10 | 2026-03-16 | 住友ゴム工業株式会社 | Method for producing trans polyisoprenoids, vectors, transformed organisms, methods for producing pneumatic tires, and methods for producing rubber products |
| JP7799273B2 (en) | 2022-03-02 | 2026-01-15 | 住友ゴム工業株式会社 | Mutant cis-prenyltransferase (CPT) family protein, method for producing polyisoprenoid, vector, transformed plant, method for producing pneumatic tire, and method for producing rubber product |
| JP7799272B2 (en) | 2022-03-02 | 2026-01-15 | 住友ゴム工業株式会社 | Mutant cis-prenyltransferase (CPT) family protein, method for producing polyisoprenoid, vector, transformed plant, method for producing pneumatic tire, and method for producing rubber product |
| JP7799274B2 (en) | 2022-03-02 | 2026-01-15 | 住友ゴム工業株式会社 | Mutant cis-prenyltransferase (CPT) family protein, method for producing polyisoprenoid, vector, transformed plant, method for producing pneumatic tire, and method for producing rubber product |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0086537A1 (en) * | 1982-02-11 | 1983-08-24 | Rijksuniversiteit Leiden | A process for the in-vitro transformation of plant protoplasts with plasmid DNA |
| WO1984002920A1 (en) * | 1983-01-17 | 1984-08-02 | Monsanto Co | Genetically transformed plants |
| GB2140822A (en) * | 1983-05-12 | 1984-12-05 | Stauffer Chemical Co | Transformation of plant cells |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0090033A1 (en) * | 1981-10-01 | 1983-10-05 | International Plant Research Institute | Process for the genetic modification of cereals with transformation vectors |
| AU9054882A (en) * | 1981-10-01 | 1983-04-27 | International Plant Research Institute | Process for the genetic modification of cerials with transformation vectors |
| CA1220733A (en) * | 1982-12-27 | 1987-04-21 | Shigeru Takahashi | Method for promoting fusion of plant protoplast |
| EP0131623B2 (en) * | 1983-01-17 | 1999-07-28 | Monsanto Company | Chimeric genes suitable for expression in plant cells |
| IL72666A0 (en) * | 1983-08-15 | 1984-11-30 | Stauffer Chemical Co | Plasmid vector |
| EP0160692A1 (en) * | 1983-11-03 | 1985-11-13 | DE WET, Johannes Martenis Jacob | Method for the transfer of exogenous genes in plants using pollen as a vector |
| NL8401048A (en) * | 1984-04-03 | 1985-11-01 | Rijksuniversiteit Leiden En Pr | METHOD FOR BUILDING FOREIGN DNA INTO THE NAME OF LOBELIC PLANTS. |
| FI864720L (en) * | 1985-11-22 | 1987-05-23 | Ciba Geigy Ag | DIREKT GENTRANSMISSION I PLASTICIDER OCH MITOKONDRIER. |
-
1985
- 1985-05-08 AT AT90122957T patent/ATE204017T1/en not_active IP Right Cessation
- 1985-05-08 EP EP85105630A patent/EP0164575B1/en not_active Expired - Lifetime
- 1985-05-08 GB GB08511630A patent/GB2159173B/en not_active Expired
- 1985-05-08 DE DE8585105630T patent/DE3585638D1/en not_active Expired - Lifetime
- 1985-05-08 AT AT85105630T patent/ATE73845T1/en not_active IP Right Cessation
- 1985-05-08 DE DE3588230T patent/DE3588230D1/en not_active Expired - Lifetime
- 1985-05-08 EP EP90122957A patent/EP0429093B1/en not_active Revoked
- 1985-05-09 AR AR85300334A patent/AR243933A1/en active
- 1985-05-09 IL IL75145A patent/IL75145A/en unknown
- 1985-05-09 CA CA000481154A patent/CA1341471C/en not_active Expired - Lifetime
- 1985-05-09 DD DD27613485A patent/DD242425A5/en unknown
- 1985-05-10 HU HU851776A patent/HUT40163A/en unknown
- 1985-05-10 BR BR8502223A patent/BR8502223A/en not_active IP Right Cessation
- 1985-05-10 AU AU42268/85A patent/AU600221B2/en not_active Expired
- 1985-05-11 JP JP60100367A patent/JP3038479B2/en not_active Expired - Lifetime
-
1999
- 1999-08-25 JP JP11238350A patent/JP2000078936A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0086537A1 (en) * | 1982-02-11 | 1983-08-24 | Rijksuniversiteit Leiden | A process for the in-vitro transformation of plant protoplasts with plasmid DNA |
| WO1984002920A1 (en) * | 1983-01-17 | 1984-08-02 | Monsanto Co | Genetically transformed plants |
| GB2140822A (en) * | 1983-05-12 | 1984-12-05 | Stauffer Chemical Co | Transformation of plant cells |
Non-Patent Citations (1)
| Title |
|---|
| NATURE VOL. 296 (1982) P 73-4 * |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2183660B (en) * | 1985-11-22 | 1990-01-10 | Ciba Geigy Ag | Direct insertion of dna into plastids and mitochondria |
| GB2183660A (en) * | 1985-11-22 | 1987-06-10 | Ciba Geigy Ag | Direct insertion of DNA into plastids and mitochondria |
| US5750871A (en) * | 1986-05-29 | 1998-05-12 | Calgene, Inc. | Transformation and foreign gene expression in Brassica species |
| WO1988003564A1 (en) * | 1986-11-03 | 1988-05-19 | Biotechnica International, Inc. | Plant transformation |
| US5508184A (en) * | 1986-12-05 | 1996-04-16 | Ciba-Geigy Corporation | Process for transforming plant protoplast |
| US6803499B1 (en) | 1989-08-09 | 2004-10-12 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US5780708A (en) * | 1990-01-22 | 1998-07-14 | Dekalb Genetics Corporation | Fertile transgenic corn plants |
| US5538877A (en) * | 1990-01-22 | 1996-07-23 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
| US5538880A (en) * | 1990-01-22 | 1996-07-23 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
| US5554798A (en) * | 1990-01-22 | 1996-09-10 | Dekalb Genetics Corporation | Fertile glyphosate-resistant transgenic corn plants |
| US5508468A (en) * | 1990-01-22 | 1996-04-16 | Dekalb Genetics Corporation | Fertile transgenic corn plants |
| US5484956A (en) * | 1990-01-22 | 1996-01-16 | Dekalb Genetics Corporation | Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin |
| US6946587B1 (en) | 1990-01-22 | 2005-09-20 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
| US5550318A (en) * | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US5489520A (en) * | 1990-04-17 | 1996-02-06 | Dekalb Genetics Corporation | Process of producing fertile transgenic zea mays plants and progeny comprising a gene encoding phosphinothricin acetyl transferase |
| US5969213A (en) * | 1990-04-17 | 1999-10-19 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof |
| US6399861B1 (en) | 1990-04-17 | 2002-06-04 | Dekalb Genetics Corp. | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US5780709A (en) * | 1993-08-25 | 1998-07-14 | Dekalb Genetics Corporation | Transgenic maize with increased mannitol content |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3588230D1 (en) | 2001-09-13 |
| EP0164575B1 (en) | 1992-03-18 |
| JP2000078936A (en) | 2000-03-21 |
| IL75145A (en) | 1990-12-23 |
| DE3585638D1 (en) | 1992-04-23 |
| ATE73845T1 (en) | 1992-04-15 |
| EP0429093A2 (en) | 1991-05-29 |
| CA1341471C (en) | 2005-01-04 |
| DD242425A5 (en) | 1987-01-28 |
| EP0164575A1 (en) | 1985-12-18 |
| AR243933A1 (en) | 1993-09-30 |
| BR8502223A (en) | 1986-01-14 |
| GB8511630D0 (en) | 1985-06-12 |
| JP3038479B2 (en) | 2000-05-08 |
| AU600221B2 (en) | 1990-08-09 |
| AU4226885A (en) | 1985-11-14 |
| EP0429093A3 (en) | 1991-08-28 |
| IL75145A0 (en) | 1985-09-29 |
| EP0429093B1 (en) | 2001-08-08 |
| HUT40163A (en) | 1986-11-28 |
| JPS60251887A (en) | 1985-12-12 |
| ATE204017T1 (en) | 2001-08-15 |
| GB2159173B (en) | 1988-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6201169B1 (en) | Transformation of hereditary material of Brassica plants and cells | |
| CA1341471C (en) | Transformation of hereditary material of plants | |
| US5508184A (en) | Process for transforming plant protoplast | |
| US5569597A (en) | Methods of inserting viral DNA into plant material | |
| US6376234B1 (en) | Method of inserting viral DNA into plant material | |
| GB2183660A (en) | Direct insertion of DNA into plastids and mitochondria | |
| EP1200557B1 (en) | Method of making plant artificial chromosomes | |
| NZ222435A (en) | Genetic modification of monocotyledonous plants | |
| JPH09238690A (en) | Gene capable of expressing insecticidal protein, production of the protein and its usage | |
| JP2815837B2 (en) | Method for selecting plant cells and method for regenerating plants using the same | |
| EP0298918A2 (en) | Inducible virus resistance in plants | |
| JP3289021B2 (en) | Method for producing protein from Hevea plant | |
| EP0317509A2 (en) | Targetted incorporation of genes into a plant genome | |
| US5215903A (en) | Process for the maintenance and proliferation of defective non-infectious virus genomes in proliferating plant materials | |
| US7247768B1 (en) | Method of making plant artificial chromosomes | |
| Hope | THE DEVELOPMENT OF REGENERATION AND TRANSFORMATION SYSTEMS | |
| Zhou | Genetic transformation of wheat by protoplast-mediated direct gene transfer | |
| Presting | Feasibility assessment of gene tagging by transformation of haploid Nicotiana plumbaginifolia protoplasts | |
| JPS63141590A (en) | Method for inserting genetic substance in monocot or growth part thereof | |
| DD258827A5 (en) | Method for direct introduction of DNA into the plastids and mitochondria of plant protoplasts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
| 732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
| PE20 | Patent expired after termination of 20 years |
Effective date: 20050507 |